Assort Health secures $120M to expand AI agents across patient journeys
On July 6, 2026, Healthcare IT Today reported that Assort Health closed a $120 million Series C round led by Menlo Ventures at a $1.2 billion valuation. Assort says its AI agents now automate scheduling, intake, referrals and other patient-journey workflows across millions of interactions, powered by its proprietary Synapse model.
Source: Healthcare IT Today